Related Experiment Videos

Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage

Angela Hays1, Michael N Diringer

  • 1Department of Neurology, Washington University, St. Louis, MO, USA.

Neurology
|May 10, 2006
PubMed

Insights

Elevated cardiac troponin I (cTnI) in intracerebral hemorrhage (ICH) patients is linked to higher in-hospital mortality. This finding suggests cTnI may be a significant prognostic biomarker in ICH cases.

Area of Science:

  • Neurology
  • Cardiology
  • Biomarkers

Background:

  • Elevated cardiac troponin I (cTnI) indicates poor outcomes in ischemic stroke.
  • The study investigates the prognostic value of cTnI in intracerebral hemorrhage (ICH).

Purpose of the Study:

  • To determine if elevated cardiac troponin I (cTnI) levels influence outcomes in patients with intracerebral hemorrhage (ICH).

Main Methods:

  • Retrospective analysis of 235 spontaneous ICH patients with cTnI and head CT within 24 hours.
  • Exclusion criteria included recent stroke, angina, or myocardial ischemia.
  • Hematoma size, location, and associated complications were assessed via CT scans.

Main Results:

  • Higher mortality (58% vs 34%) was observed in the 18% of patients with peak cTnI > 0.4 ng/mL (p = 0.009).
  • Elevated cTnI independently predicted in-hospital mortality (Exp [beta] 3.68, p = 0.023).
  • Cardiac events caused death in 1.2% of patients, all with elevated cTnI.

Conclusions:

  • Elevated cTnI is frequent in ICH and independently associated with increased in-hospital mortality.
  • While cardiac deaths were more common in elevated cTnI groups, this requires further investigation due to low frequency.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...